Replacement of valsartan and candesartan by telmisartan in hypertensive patients with type 2 diabetes: metabolic and antiatherogenic consequences. - Miura,Y.; Yamamoto,N.; Tsunekawa,S.; Taguchi,S.; Eguchi,Y.; Ozaki,N.; Oiso,Y. (Diabetes Care, 2005)